HT
IOVA icon

HAP Trading’s Iovance Biotherapeutics IOVA Stock Holding History

HAP Trading’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-100,400
Closed -$88.1K – 877
2023
Q4 		$88.1K Buy
+100,400
New +$525K 0.01% 384
2021
Q3 		– Sell
-42,000
Closed -$137K – 2571
2021
Q2 		$137K Sell
42,000
-127,600
-75% -$3.32M ﹤0.01% 1116
2021
Q1 		$141K Sell
169,600
-100,700
-37% -$4.17M 0.01% 852
2020
Q4 		$1.89M Buy
270,300
+252,800
+1,445% +$10M 0.05% 275
2020
Q3 		$41K Sell
17,500
-1,700
-9% -$52.1K ﹤0.01% 1016
2020
Q2 		$15K Sell
19,200
-66,400
-78% -$2.18M ﹤0.01% 1367
2020
Q1 		$465K Buy
85,600
+14,100
+20% +$374K 0.03% 355
2019
Q4 		$248K Buy
+71,500
New +$1.63M 0.01% 424
2018
Q2 		– Sell
-50,100
Closed -$19K – 1058
2018
Q1 		$19K Buy
+50,100
New +$759K ﹤0.01% 777

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HAP Trading's IOVA Position: Q4 2021 in Review

HAP Trading sold out of Iovance Biotherapeutics (IOVA) in Q4 2021, closing a stake of 14,264 shares — an estimated $352K sold.

HAP Trading first reported a position in IOVA in Q3 2021 and held it in 1 quarter. The position peaked at $352K in Q3 2021. 246 funds tracked by Wall St. Rank hold IOVA as of Q4 2021.

  • HAP Trading reported no remaining Iovance Biotherapeutics position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 14,264 Iovance Biotherapeutics shares in Q4 2021, an estimated $352K.
  • HAP Trading first reported a position in Iovance Biotherapeutics in Q3 2021 and held it in 1 quarter.
  • HAP Trading's Iovance Biotherapeutics position peaked at $352K in Q3 2021.
  • 246 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.